Physician

Rekha Lall, MD

According to 2025 Medicare claims, Rekha Lall, MD (NPI: 1225083173) practices internal medicine in the Auburn-Opelika, AL market, with the plurality of this provider's patient population coming from Lee, AL. This provider's primary affiliated billing organization is AUBURN PRIMARY CARE LLC (NPI: 1821230277; TIN: 26-3644352) and primary practice location at 36830-5789.

Lall's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 216 traditional Medicare patients, billed 2,910 HCPCS/CPT codes, and received $150,490 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 3,854 prescription claims across 377 beneficiaries totaling $289,578 in drug costs, led by Januvia (Sitagliptin Phosphate). DME data shows 36 claims. Open Payments data shows 3 records totaling $111. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $435,367 and ending at $289,578. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $22,905 and ending at $8,754.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	474	3,301	$175,647
2016	463	3,137	$156,589
2017	378	2,602	$134,090
2018	348	2,797	$142,797
2019	330	2,726	$137,388
2020	277	2,674	$118,200
2021	239	1,835	$98,036
2022	236	1,707	$101,928
2023	219	2,604	$153,001
2024	216	2,910	$150,490

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	322	7,287	$435,367
2016	298	5,603	$307,897
2017	342	5,375	$268,172
2018	365	7,438	$390,954
2019	367	7,570	$452,687
2020	364	7,450	$461,496
2021	345	6,467	$378,772
2022	328	3,511	$245,374
2023	331	4,086	$393,831
2024	377	3,854	$289,578

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	143	659	$26,832
2016	129	496	$16,633
2017	52	296	$8,033
2018	40	361	$8,037
2019	42	335	$7,409
2020	39	269	$7,278
2021	33	178	$6,199
2022	12	145	$6,572
2023	N/R	113	$10,187
2024	11	36	$1,576

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	90	138	$123
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	166	340	$81
99490	Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month	164	1,099	$43
99439	Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month	103	226	$34
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	132	271	$12

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Januvia	Sitagliptin Phosphate	42	3,030	$50,784
Jardiance	Empagliflozin	33	1,230	$24,282
Mounjaro	Tirzepatide	19	588	$21,146
Ozempic	Semaglutide	13	540	$17,631
Eliquis	Apixaban	20	910	$17,463

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	21	$1,388
A4253	Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips	N	11	15	$188

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	3	$111	GlaxoSmithKline, LLC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Rekha Lall, MD?

Tedicare shows public-source Medicare data for Rekha Lall, MD (NPI 1225083173), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Rekha Lall, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Rekha Lall, MD?

Rekha Lall, MD is linked to AUBURN PRIMARY CARE LLC (billing NPI 1821230277) in the available physician profile data.

Does Rekha Lall, MD have Open Payments data?

Rekha Lall, MD has 3 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.